返回 Agenda
Session 12: Co-track Grand Q&A Panel and Closing Remarks
Session Chair(s)
Ramesh Raghavachari, PhD
Supervisor, Unit 3/DPQA IV/OPQA I/OPQ/CDER
FDA, United States
Session 12: Co-track Grand Q&A Panel and Closing Remarks
Speaker(s)
Speaker
Nedim Emil Altaras, PhD
Moderna, United States
Senior Vice President, Technical Development
Panelists
Paul C. Brown, PhD
FDA, United States
Associate Director for Pharmacology and Toxicology, OND, CDER
Speaker
Daniel Capaldi, PhD
Ionis Pharmaceuticals, Inc, United States
Vice President, Analytical and Process Development
Speaker
Jeffrey Foy, PhD
PepGen Inc., United States
Senior VP, Toxicology
Panelist
Lois Freed, PhD
FDA, United States
Director, Division of Pharmacology/Toxicology-Neuroscience (DPT-N), CDER
Speaker
Laura Sepp-Lorenzino, PhD
Intellia Therapeutics, Inc., United States
Chief Scientific Officer
Panelist
Barry Ticho, MD, PhD
Stoke Therapeutics, United States
Chief Medical Officer